13F-HR filed by Jones Hill Capital LP
Jones Hill Capital LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-13, with 29 holding rows worth $470,359,288.
- Accession
- 0002102314-26-000005
- Filer
- CIK 2102314
- Filed
- 2026-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 29 entries on the cover page, a total value of $470,359,288 stated on the cover page (in dollars after the unit check, H1), rows summing to $470,359,288 with VALUE read as dollars as filed, 13F file number 028-26921. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,431,590 | $81,915,580 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 343,043 | $43,340,053 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,089,701 | $28,571,960 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 52,545 | $28,214,038 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 892,621 | $26,501,917 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 3,655,075 | $25,293,119 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,339,212 | $24,976,304 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 677,879 | $23,441,056 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 367,900 | $22,206,444 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 233,808 | $19,354,626 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 512,856 | $16,283,178 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 894,058 | $16,057,282 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 122,375 | $13,047,622 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 98,442 | $12,157,587 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 420,751 | $10,131,684 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,759,492 | $9,307,713 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 539,814 | $8,296,941 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 747,313 | $8,093,400 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260839 | COMMON STOCK | 625,428 | $7,980,461 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 340,000 | $7,432,400 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 574,166 | $7,182,817 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 659,213 | $6,717,380 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 653,572 | $6,130,505 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 57,100 | $5,566,108 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 11,123 | $5,525,128 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 49,850 | $2,529,888 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 40,567 | $2,177,231 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 161,486 | $1,752,123 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 26,760 | $174,743 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002102314-26-000005 | this filing | 2026-08-13 | acceptance time not in the bulk data set |